We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




In Vitro Culture System Yields Clues About Embryonic Blood Cell Development

By LabMedica International staff writers
Posted on 20 Mar 2016
Developmental researchers employed a robust in vitro culture system, which models HSC (hematopoietic stem cell) development in the embryo, to study how these cells give rise to the various types of blood cells found in the adult.

Developing HSCs are embedded in the complex embryonic AGM (aorta–gonad–mesonephros) microenvironment. More...
The AGM region is derived from the mesoderm layer of the embryo. During organogenesis (around the fourth week in human embryos), the visceral region of the mesoderm, the splanchnopleura, transforms into distinct structures consisting of the dorsal aorta, genital ridges, and mesonephros. For a period during embryonic development, the dorsal aorta produces hematopoietic stem cells, which eventually colonize the liver and give rise to all mature blood lineages in the adult. By birth, the dorsal aorta has become the descending aorta, while the genital ridges have formed the gonads. The mesonephros have formed nephrons and other associated structures of the kidneys.

The location for HSC development suggested that this process may require signals derived from different compartments of the AGM region. Investigators at the University of Edinburgh (United Kingdom) sought to test this hypothesis. However, the analysis of HSC development in vivo was significantly hampered by low accessibility of embryos developing in utero, fast maturation of HSCs into mature blood cells, and lack of uniquely specific markers for HSC precursors and their low numbers in the AGM region.

To overcome these difficulties, the investigators developed a cell culture system that modeled HSC development in the embryo, and used it in combination with functional HSC analysis using long-term reconstitution assays in mice.

Results obtained with these tools were published in the March 8, 2016, online edition of the journal Nature Communications. The investigators reported that stage-specific reciprocal dorsoventral inductive interactions and lateral input from the urogenital ridges were required to drive HSC development in the aorta. Furthermore, the results suggested that these inductive interactions in the AGM region were mediated by the interplay between spatially polarized signaling pathways. Specifically, Shh (Sonic hedgehog) produced in the dorsal region of the AGM, stem cell factor in the ventral and lateral regions, and BMP (Bone morphogenetic protein) inhibitory signals in the ventral tissue were integral parts of the regulatory system involved in the development of HSCs.

Senior author Dr. Alexander Medvinsky, professor of hematopoietic stem cell biology at the University of Edinburgh, said, "There is a pressing need to improve treatments for diseases like leukemia and this type of research brings us a step closer to that milestone. The more we understand about how embryos develop these blood stem cells, the closer we come to being able to make them in the lab."

Related Links:

University of Edinburgh



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.